BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Reactive Biosciences
Reactive Bioscience is using the world’s leading boron-based discovery platform to discover and develop medicines in innovative and imaginative new ways.
Website
